Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study (IRIS imaging)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Seung-Jung Park, MD
- Email: sjpark@amc.seoul.kr
Study Locations
-
-
-
Busan, South Korea
- Recruiting
- Inje University Busan Paik Hospital
-
Contact:
- Tae-hyun Yang, MD
-
Principal Investigator:
- Tae-hyun Yang, MD
-
Cheonan, South Korea
- Recruiting
- Soon Chun Hyang University Hospital Cheonan
-
Contact:
- Seung-jin Lee, MD
-
Principal Investigator:
- Seung-jin Lee, MD
-
Daegu, South Korea
- Recruiting
- Keimyung University Dongsan Medical Center
-
Principal Investigator:
- Seung-Ho Huh, MD
-
Contact:
- Seung-Ho Huh, MD
-
Daejeon, South Korea
- Recruiting
- Chungnam National University Hospital
-
Contact:
- Jin-ok Jeong, MD
-
Principal Investigator:
- Jin-ok Jeong, MD
-
Ilsan, South Korea
- Recruiting
- Inje University Ilsan Paik Hospital
-
Contact:
- Sung-yun Lee, MD
-
Principal Investigator:
- Sung-yun Lee, MD
-
Incheon, South Korea
- Terminated
- Gachon University Gil Hospital
-
Jeju City, South Korea
- Recruiting
- Jeju National University Hospital
-
Contact:
- Song-yi Kim, MD
-
Principal Investigator:
- Song-yi Kim, MD
-
Pusan, South Korea
- Recruiting
- Pusan National University Hospital
-
Contact:
- Jun-hyuck Oh, MD
-
Principal Investigator:
- Jun-hyuck Oh, MD
-
Seoul, South Korea
- Recruiting
- Chung-Ang University Hospital
-
Contact:
- Sang-wook Kim, MD
-
Principal Investigator:
- Sang-wook Kim, MD
-
Seoul, South Korea
- Recruiting
- Korea University Guro Hospital
-
Contact:
- Seung-un Na, MD
-
Principal Investigator:
- Seung-un Na, MD
-
Seoul, South Korea
- Withdrawn
- Kangbuk Samsung Hospital
-
Suwon, South Korea
- Active, not recruiting
- Ajou University Hospital
-
Ulsan, South Korea
- Withdrawn
- Ulsan University Hospital
-
Wŏnju, South Korea
- Recruiting
- Wonju Severance Christian Hospital
-
Contact:
- Jung-han Yoon, MD
-
Principal Investigator:
- Jung-han Yoon, MD
-
-
Songpa-gu
-
Seoul, Songpa-gu, South Korea, 138-736
- Recruiting
- Asan Medical Center
-
Contact:
- Seung-jung Park, MD
-
Principal Investigator:
- Seung-jung Park, MD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with intracoronary imaging
- Written consent
Exclusion Criteria:
- Severe calcification and/or severe tortuosity
- Lesion with previous bypass graft surgery (CABG)
- Left ventricular ejection fraction less than 30 %
- Coronary spasm
- Life expectancy less than 2 years
- Pregnancy or breast-feeding
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
VH-IVUS
Patients with IVUS-derived virtual histology
|
|
|
OCT
Patients with Optical coherence tomography
|
|
|
NIRS
Patients with Near-infrared spectroscopy
|
|
|
gray scale IVUS
Patients with gray-scale IVUS(Intravascular ultrasound)
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Target Vessel Failure
Time Frame: 2 years
|
defined as composite event of cardiac death, non-fatal myocardiac infarction, target vessel revascularization
|
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac death
Time Frame: 5 years
|
5 years
|
|
|
All-cause death
Time Frame: 5 years
|
5 years
|
|
|
Number of myocardial infarction events
Time Frame: 5 years
|
Q wave myocardial infarction or non Q wave myocardial infarction
|
5 years
|
|
Composite event of death or myocardial infarction
Time Frame: 5 years
|
5 years
|
|
|
Composite event of cardiac death or myocardial infarction
Time Frame: 5 years
|
5 years
|
|
|
Target Vessel revascularization
Time Frame: 5 years
|
5 years
|
|
|
Target Lesion revascularization
Time Frame: 5 years
|
5 years
|
|
|
Number of stent thrombosis events
Time Frame: 5 years
|
DEFINITE stent thrombosis : acute coronary syndrome and angiographic or pathologic evidence of stent thrombosis; PROBABLE stent thrombosis : unexplained death within 30 days or target-vessel infarction without angiographic information Academic Research Consortium (ARC) stent thrombosis is reported as a cumulative value at different time points and within the different separate time points.
Time 0 is the time point after the guide catheter has been removed.
Acute stent thrombosis: 0-24 hours after stent implantation; Subacute stent thrombosis: >24 hours to 30 days post; late stent thrombosis: >30 days to 1 year post; Very late stent thrombosis: >1 year post;
|
5 years
|
|
Number of stroke
Time Frame: 5 years
|
5 years
|
|
|
Procedural success
Time Frame: 7 days
|
Defined as mean lesion diameter stenosis less than 30% and without the occurrence of in-hospital myocardial infarction (MI), target vessel revascularization (TVR), or death
|
7 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- AMCCV2016-09
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.